Prospective Observational Study to Assess Effectiveness and Safety of Intravenous Ferric Carboxymaltose 1000 Mg in Patients of Chronic Heart Failure With Iron DeficiEncy - PRIDE-HF Study. ccm 2023, 7 (6), 349-354.